chr17-44852391-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004247.4(EFTUD2):c.2715+18G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0339 in 1,613,486 control chromosomes in the GnomAD database, including 1,116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.024 ( 69 hom., cov: 31)
Exomes 𝑓: 0.035 ( 1047 hom. )
Consequence
EFTUD2
NM_004247.4 intron
NM_004247.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.772
Publications
1 publications found
Genes affected
EFTUD2 (HGNC:30858): (elongation factor Tu GTP binding domain containing 2) This gene encodes a GTPase which is a component of the spliceosome complex which processes precursor mRNAs to produce mature mRNAs. Mutations in this gene are associated with mandibulofacial dysostosis with microcephaly. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
EFTUD2 Gene-Disease associations (from GenCC):
- mandibulofacial dysostosis-microcephaly syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-44852391-C-G is Benign according to our data. Variant chr17-44852391-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259255.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0237 (3601/152190) while in subpopulation NFE AF = 0.0389 (2648/68002). AF 95% confidence interval is 0.0377. There are 69 homozygotes in GnomAd4. There are 1608 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 3601 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFTUD2 | NM_004247.4 | c.2715+18G>C | intron_variant | Intron 26 of 27 | ENST00000426333.7 | NP_004238.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EFTUD2 | ENST00000426333.7 | c.2715+18G>C | intron_variant | Intron 26 of 27 | 1 | NM_004247.4 | ENSP00000392094.1 |
Frequencies
GnomAD3 genomes AF: 0.0237 AC: 3598AN: 152072Hom.: 69 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
3598
AN:
152072
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0256 AC: 6433AN: 250992 AF XY: 0.0271 show subpopulations
GnomAD2 exomes
AF:
AC:
6433
AN:
250992
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0350 AC: 51097AN: 1461296Hom.: 1047 Cov.: 31 AF XY: 0.0346 AC XY: 25164AN XY: 726930 show subpopulations
GnomAD4 exome
AF:
AC:
51097
AN:
1461296
Hom.:
Cov.:
31
AF XY:
AC XY:
25164
AN XY:
726930
show subpopulations
African (AFR)
AF:
AC:
167
AN:
33468
American (AMR)
AF:
AC:
512
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
AC:
1185
AN:
26122
East Asian (EAS)
AF:
AC:
3
AN:
39696
South Asian (SAS)
AF:
AC:
2458
AN:
86200
European-Finnish (FIN)
AF:
AC:
803
AN:
53400
Middle Eastern (MID)
AF:
AC:
80
AN:
5498
European-Non Finnish (NFE)
AF:
AC:
44076
AN:
1111864
Other (OTH)
AF:
AC:
1813
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2545
5090
7635
10180
12725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1658
3316
4974
6632
8290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0237 AC: 3601AN: 152190Hom.: 69 Cov.: 31 AF XY: 0.0216 AC XY: 1608AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
3601
AN:
152190
Hom.:
Cov.:
31
AF XY:
AC XY:
1608
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
301
AN:
41524
American (AMR)
AF:
AC:
184
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
166
AN:
3468
East Asian (EAS)
AF:
AC:
3
AN:
5178
South Asian (SAS)
AF:
AC:
107
AN:
4810
European-Finnish (FIN)
AF:
AC:
149
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2648
AN:
68002
Other (OTH)
AF:
AC:
41
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
186
373
559
746
932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.